Literature DB >> 15465588

Mood disorders in opioid-dependent patients.

Jamshid Ahmadi1, Behzad Majdi, Shiva Mahdavi, Mohammadsadegh Mohagheghzadeh.   

Abstract

AIMS: To assess the rate of current mood disorders in opioid-dependent outpatients.
DESIGN: Prevalence study of DSM-IV mood disorders. SETTINGS: Private and government clinics. PARTICIPANTS: Five hundred unpaid opioid-dependent patients who had voluntarily sought treatment. MEASUREMENTS: The Research version of structured clinical interview for DSM-IV Axis I Disorders (SCID-I).
RESULTS: The mean age of the subjects (487 men and 13 women) was 33.4 years, ranging from 16 to 67. The majority (68.2%) had private sector job and 13.4% were unemployed. The majority (59.8%) had education at the level of primary, guidance or high school and only 3.8% were illiterate. Three hundred and thirty six (67.2%) subjects were diagnosed as having mood disorders. Of the subjects 274 (54.8%) had substance induced depression, 37 (7.4%) major depression, 14 (2.8%) dysthymia, five (1%) depression due to general medical condition, three (0.6%) cylothymia, three (0.6%) bipolar mood disorder type I. None was diagnosed as having bipolar mood disorder type II. Of the participants 319 (63.8%) reported more than 5 years use of opioid. Of the subjects only 16 (3.2%) reported no episode of abstinence and the majority 484 (96.8%) reported one or more episodes of abstinences. About 4.2% (21) reported less than 1 g/day and the majority 86.4% (432) reported between 1 and 5 g/day current use of opioid.
CONCLUSION: Due to high rates of mood disorders in opioid-dependent subjects, psychiatric services should be open and accessible to the patients, especially those who voluntarily seek help and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15465588     DOI: 10.1016/j.jad.2003.09.015

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts.

Authors:  Dingyan Chen; Yan Liu; Wulong He; Hongxing Wang; Zengzhen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

2.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

3.  Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.

Authors:  Bradley D Stein; Joshua Mendelsohn; Adam J Gordon; Andrew W Dick; Rachel M Burns; Mark Sorbero; Regina A Shih; Rosalie Liccardo Pacula
Journal:  J Addict Dis       Date:  2016-07-22

4.  Study of sociodemographic correlates, anxiety, and depression among opioid dependents admitted in treatment centres in Sikkim, India.

Authors:  Bishnu Sharma; Samrat Singh Bhandari; Sanjiba Dutta; Geeta Soohinda
Journal:  Open J Psychiatry Allied Sci       Date:  2019-02-25

Review 5.  The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.

Authors:  Philip J Freda; Jason H Moore; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

6.  Differences between expressive suppression and cognitive reappraisal in opioids and stimulant dependent patients.

Authors:  Banafsheh Mohajerin; Behrouz Dolatshahi; Abbas Pour Shahbaz; Ali Farhoudian
Journal:  Int J High Risk Behav Addict       Date:  2013-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.